A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 400 KRW 3.79% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABL Bio Inc
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Operating Expenses
-â‚©60.1B
CAGR 3-Years
2%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Expenses
-â‚©965B
CAGR 3-Years
-39%
CAGR 5-Years
-32%
CAGR 10-Years
-23%
SK Bioscience Co Ltd
KRX:302440
Operating Expenses
-â‚©154.2B
CAGR 3-Years
-39%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Operating Expenses
-â‚©121.9B
CAGR 3-Years
-15%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Expenses
-â‚©115.4B
CAGR 3-Years
-31%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Operating Expenses
-â‚©37.9B
CAGR 3-Years
-20%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
No Stocks Found

ABL Bio Inc
Glance View

Market Cap
1.3T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
8 401.38 KRW
Overvaluation 69%
Intrinsic Value
Price
A

See Also

What is ABL Bio Inc's Operating Expenses?
Operating Expenses
-60.1B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Operating Expenses amounts to -60.1B KRW.

What is ABL Bio Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-34%

Over the last year, the Operating Expenses growth was 3%. The average annual Operating Expenses growth rates for ABL Bio Inc have been 2% over the past three years , -34% over the past five years .

Back to Top